Atlas Trials

COMPLEMENT Study- A First in Human Study of Metabolic Neuromodulation Therapy

Clinical trial NCT02278068 · COMPLETED

Trial details

NCT number
NCT02278068
Sponsor
Metavention
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
DiabetesEndocrine, Nutritional and Metabolic Diseases (E00-E89)
Start date
2014-10-01
Primary completion
2019-05-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.